VeriSeq NIPT Solution v2

Comprehensive, IVD, in-lab aneuploidy screening solution providing reagents, instruments, and software for accurate NIPT results in 26 hours. Read More...

This product is only available in select countries. Please select the country where you would like this product to be shipped to see availability.

Select Product(s)

VeriSeq NIPT Sample Prep Kit(24 Samples)

20025895

Price
 
 

VeriSeq NIPT Sample Prep Kit(48 samples )

RH-200-1001

Price
 
 

VeriSeq NIPT Sample Prep Kit(96 samples )

RH-200-1002

Price
 
 

Streck cell free DNA BCT CE

15073345

Price
 
 
Other Illumina Materials Required
What materials do I need?

NextSeq 550 Dx Sequencing System

20005715

VeriSeq NIPT Solution Enablement

RH-500-1001

VeriSeq Onsite Server v2

20028403

Product Highlights

VeriSeq NIPT Solution v2 makes NGS-based noninvasive prenatal testing accessible to any lab, providing:

  • Most comprehensive view of genome-wide fetal chromosomal anomalies - IVD in-lab NIPT solution offers the broadest test menu among all IVD screening tests validated in a clinical accuracy study of >2300 samples
  • Unparalleled performance - Superior accuracy, fastest results, low failure rates
  • Simple, scalable solution - Easy-to-implement solution analyzes 24, 48, or 96 samples per run
Comprehensive screening beyond common aneuploidies

VeriSeq NIPT Solution v2 uses PCR-free, whole-genome sequencing to expand prenatal screening beyond aneuploidies 21, 18, and 13 to all rare autosomal aneuploidies (RAAs), sex chromosome aneuploidies (SCAs), and partial duplications and deletions ≥7 Mb for all autosomes. This enables the VeriSeq NIPT Solution v2 to detect anomalies that targeted assays miss and deliver more insights into the health of a pregnancy.

Accurate, fast results

Extensive validation of the VeriSeq NIPT Solution v2 confirmed high concordance with clinical reference data and a low test failure rate. An efficient 3-step workflow allows sample to report in 26 hours.

Automated solution

Sample preparation is automated on the VeriSeq NIPT Microlab STAR system, optimized for use in the VeriSeq NIPT workflow. Learn more on the Hamilton website.

Frequently Purchased Together

Specifications

Intended Use

The VeriSeq NIPT Solution v2 is an in vitro diagnostic test intended for use as a screening test for the detection of genome-wide fetal genetic anomalies from maternal peripheral whole blood specimens in pregnant women of at least 10 weeks gestation. VeriSeq NIPT Solution v2 uses whole-genome sequencing to detect partial duplications and deletions for all autosomes and aneuploidy status for all chromosomes. The test offers an option to request the reporting of sex chromosome aneuploidy (SCA). This product must not be used as the sole basis for diagnosis or other pregnancy management decision.

For In Vitro Diagnostic Use. Not available in all countries or regions.

For In Vitro Diagnostic Use.

Contact an Illumina representative for regional availability.

VeriSeq NIPT Solution v2 Enablement Schedule*

 

Supporting Data and Figures